Junior Lanzol 15mg Tablet DT contains Lansoprazole 15mg, a proton pump inhibitor indicated for the treatment and management of acid-related gastrointestinal conditions in pediatric patients. Lansoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This formulation is designed as a dispersible tablet, facilitating ease of administration in children who may have difficulty swallowing conventional tablets. Junior Lanzol 15mg is primarily prescribed for conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease, including Helicobacter pylori-associated ulcers when used in combination therapy. The tablet should be administered once daily, preferably before meals, as directed by a healthcare professional. It is important to adhere to the prescribed dosage and duration to achieve optimal therapeutic outcomes and minimize the risk of relapse. Common adverse effects may include headache, abdominal pain, diarrhea, and nausea; however, these are generally mild and transient. Caution is advised in patients with known hypersensitivity to Lansoprazole or other proton pump inhibitors. Junior Lanzol 15mg Tablet DT offers an effective and convenient option for pediatric acid suppression therapy, improving patient compliance and clinical efficacy.